Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Myopathy breakthrough paves way for new treatments
Dr Charlotte Maile and Professor Richard Piercy.

RVC study reveals mechanisms that underlie form of 'tying-up'

New research has revealed the molecular mechanisms that underlie a common form of ‘tying-up’ in horses.

Tying-up, scientifically known as Type 1 Polysaccharide Storage Myopathy (PSSM1), is a common condition that damages equine muscle tissue.  

Animals affected by the condition have a mutation of a key enzyme (glycogen synthase) which is involved in energy metabolism in muscle.

They also suffer from a build-up of polysaccharide (a form of carbohydrate) and increased storage of glycogen. Horses that carry the condition are prone to ‘tying up and muscle weakness.

Until now, nobody knew the precise mechanism by which the mutation caused increased enzyme activity in muscles. But new research, published in the journal Biochim Biohys Acta, shows that the mutation leads to a change in the enzyme’s structure, leaving it permanently active.

This hyperactivity, the team explains, accounts for the increased muscle glycogen and the accumulation of polysaccharide.

Led by
Dr Charlotte Maile and Professor Richard Piercy of the RVC, the research was conducted by an international team of scientists from the University of Copenhagen, University of Minnesota, Indiana University School of Medicine and Liverpool John Moore’s University.

It is hoped that the breakthrough will enable the team to work towards improving treatments and management for this disorder, to improve the welfare of affected horses.

"PSSM1 is a very common disease, especially in some breeds. Finally we know the reason why these horses store excessive glycogen and polysaccharide in their muscles. Our goal now is to use this information in designing new treatments and management strategies,” said Professor Richard Piercy, Professor of Comparative Neuromuscular Disease.

Prof Richard Piercy added: “Managing horses that tie-up is hard, and some recommended treatments work poorly in some animals. By revealing the precise mechanism for this form of tying up, our work should make a real difference.

“Our hope is that by targeting specific approaches to the problem, rather than a ‘one treatment fits all’ - horse welfare will be improved allowing them to get back to exercise, which has to be good for the horse and their owner”.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'